Ei, A Pharmaceutical Solutionworks, has launched EnDev Laboratories, a standalone, full service R&D provider located in a 10,000-sq.-ft. lab with office space in Kannapolis, NC.  Endev will have access to advanced scientific capabilities offered through the David H. Murdock Research Institute (DHMRI) and the ability to collaborate with researchers on campus to advance novel dermatological technologies. 
 
The launch allows the company to broaden its scientific foundation for dermatological product development and add a skin biology research capability that includes early safety screening, drug delivery, and drug target engagement.
 
Endev offers topical research and development services that include early formulation screening; formulation development; analytical method development and validation, process development and scale up; project management; clinical and registration batch manufacturing; and regulatory affairs support.
 
Also, EnDev is fully integrated with Ei’s commercial manufacturing capabilities, offering early development through to commercial launch. 
 
Ei’s chief scientific officer, Charles W. Gray, Jr., Ph.D., said: “The combination of the EnDev team’s experience in topical product development, the addition of advanced skin biology applications, and our expansion to best in class facilities at the NC Research Campus will significantly accelerate our progress toward creating the premier dermatology development capability.